Advertisement
Advertisement
TXMD
TherapeuticsMD, Inc.
2.08
USDSponsored
+0.01
+0.48%
Aug 10, 14:07 UTC -4
Open
TXMD Earnings Reports
Positive Surprise Ratio
TXMD beat 15 of 32 last estimates.
47%
Next Report
Today
Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/--
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q2 25 (Revenue/ EPS)
--
/--
TherapeuticsMD, Inc. earnings per share and revenue
On May 11, 2026, TXMD reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q2 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Oruka Therapeutics, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.52
Actual
-$0.55
Surprise
-4.62%
Relay Therapeutics, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.39
Actual
-$0.41
Surprise
-2.78%
Guardian Pharmacy Services, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.27
Actual
$0.28
Surprise
+3.76%
Xeris Biopharma Holdings, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.00
Actual
$0.00
Surprise
-100.00%
Cronos Group Inc. Common Share
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.00
Actual
$0.03
Surprise
0.00%
Ironwood Pharmaceuticals, Inc. - Class A
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.36
Actual
$0.31
Surprise
-14.62%
Nature's Sunshine Products Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.27
Actual
$0.21
Surprise
-23.75%
Profound Medical Corp. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.26
Actual
$0.26
Surprise
+199.01%
Organogenesis Holdings Inc. Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.35
Actual
-$0.71
Surprise
-98.88%
Tonix Pharmaceuticals Holding Corp.
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$2.75
Actual
-$2.44
Surprise
+11.29%
FAQ
What were TherapeuticsMD, Inc.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, TherapeuticsMD, Inc. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to TherapeuticsMD, Inc.'s Q1 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is TherapeuticsMD, Inc. expected to report next?
The next earning report is scheduled for Aug 10, 2026.
What are the forecasts for TherapeuticsMD, Inc.'s next earnings report?
Based on --
analysts, TherapeuticsMD, Inc. is expected to report EPS of -- and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement